C	NN	B-NP	O	Other	###	1	C	C	NN	NN	_	2	compound	_	_
D4	NN	B-NP	B-protein	B-Protein	###	2	D4	D4	NN	NN	_	11	nsubjpass	_	_
+	+	O	O	Other	###	3	+	+	+	+	_	2	cc	_	_
T	NN	I-NP	I-cell_type	Other	###	4	T	T	NN	NN	_	2	conj	_	_
cells	NNS	I-NP	I-cell_type	Other	###	5	cells	cells	NNS	NNS	_	2	conj	_	_
from	IN	B-PP	O	Other	###	6	from	from	IN	IN	_	9	case	_	_
active	JJ	B-NP	O	Other	###	7	active	active	JJ	JJ	_	9	amod	_	_
RA	NN	I-NP	O	Other	###	8	RA	RA	NN	NN	_	9	compound	_	_
patients	NNS	I-NP	O	Other	###	9	patients	patients	NNS	NNS	_	2	nmod	_	_
are	VBP	B-VP	O	Other	###	10	are	are	VBP	VBP	_	11	auxpass	_	_
characterized	VBN	I-VP	O	Other	###	11	characterized	characterized	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	12	by	by	IN	IN	_	14	case	_	_
their	PRP$	B-NP	O	Other	###	13	their	their	PRP$	PRP$	_	14	nmod:poss	_	_
resistance	NN	I-NP	O	Other	###	14	resistance	resistance	NN	NN	_	11	nmod	_	_
to	TO	B-PP	O	Other	###	15	to	to	TO	TO	_	17	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	16	IL-10	IL-10	NN	NN	_	17	compound	_	_
inhibition	NN	I-NP	O	Other	###	17	inhibition	inhibition	NN	NN	_	14	nmod	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	20	case	_	_
IFN-gamma	NN	B-NP	B-protein	B-Protein	###	19	IFN-gamma	IFN-gamma	NN	NN	_	20	compound	_	_
production	NN	I-NP	O	Other	###	20	production	production	NN	NN	_	17	nmod	_	_
,	,	O	O	Other	###	21	,	,	,	,	_	11	punct	_	_
due	JJ	B-PP	O	Other	###	22	due	due	JJ	JJ	_	26	case	_	_
to	TO	B-PP	O	Other	###	23	to	to	TO	TO	_	22	mwe	_	_
constitutive	JJ	B-NP	O	Other	###	24	constitutive	constitutive	JJ	JJ	_	26	amod	_	_
STAT3	NN	I-NP	B-protein	B-Protein	###	25	STAT3	STAT3	NN	NN	_	26	compound	_	_
phosphorylation	NN	I-NP	O	Other	###	26	phosphorylation	phosphorylation	NN	NN	_	11	nmod	_	_
and	CC	O	O	Other	###	27	and	and	CC	CC	_	26	cc	_	_
impaired	JJ	B-NP	O	Other	###	28	impaired	impaired	JJ	JJ	_	33	amod	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	29	IL-10	IL-10	NN	NN	_	33	compound	_	_
-	-	O	O	Other	###	30	-	-	-	-	_	33	punct	_	_
mediated	NN	B-NP	O	Other	###	31	mediated	mediated	NN	NN	_	33	amod	_	_
STAT3	NN	I-NP	B-protein	B-Protein	###	32	STAT3	STAT3	NN	NN	_	33	compound	_	_
activation	NN	I-NP	O	Other	###	33	activation	activation	NN	NN	_	26	conj	_	_
.	.	O	O	Other	###	34	.	.	.	.	_	11	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	4	det	_	_
defective	JJ	I-NP	O	Other	###	2	defective	defective	JJ	JJ	_	4	amod	_	_
STAT3	NN	I-NP	B-protein	B-Protein	###	3	STAT3	STAT3	NN	NN	_	4	compound	_	_
signaling	NN	I-NP	O	Other	###	4	signaling	signaling	NN	NN	_	7	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	5	is	is	VBZ	VBZ	_	7	auxpass	_	_
possibly	RB	I-VP	O	Other	###	6	possibly	possibly	RB	RB	_	7	advmod	_	_
associated	VBN	I-VP	O	Other	###	7	associated	associated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	###	8	with	with	IN	IN	_	10	case	_	_
SOCS1	NN	B-NP	B-protein	B-Protein	###	9	SOCS1	SOCS1	NN	NN	_	10	compound	_	_
predominance	NN	I-NP	O	Other	###	10	predominance	predominance	NN	NN	_	7	nmod	_	_
over	IN	B-PP	O	Other	###	11	over	over	IN	IN	_	12	case	_	_
SOCS3	NN	B-NP	B-protein	B-Protein	###	12	SOCS3	SOCS3	NN	NN	_	10	nmod	_	_
.	.	O	O	Other	###	13	.	.	.	.	_	7	punct	_	_

These	DT	B-NP	O	Other	###	1	These	These	DT	DT	_	2	det	_	_
abnormalities	NNS	I-NP	O	Other	###	2	abnormalities	abnormalities	NNS	NNS	_	7	nsubjpass	_	_
in	IN	B-PP	O	Other	###	3	in	in	IN	IN	_	5	case	_	_
active	JJ	B-NP	O	Other	###	4	active	active	JJ	JJ	_	5	amod	_	_
RA	NN	I-NP	O	Other	###	5	RA	RA	NN	NN	_	2	nmod	_	_
are	VBP	B-VP	O	Other	###	6	are	are	VBP	VBP	_	7	auxpass	_	_
thought	VBN	I-VP	O	Other	###	7	thought	thought	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	###	8	to	to	TO	TO	_	10	mark	_	_
be	VB	I-VP	O	Other	###	9	be	be	VB	VB	_	10	auxpass	_	_
induced	VBN	I-VP	O	Other	###	10	induced	induced	VBN	VBN	_	7	xcomp	_	_
mainly	RB	B-ADVP	O	Other	###	11	mainly	mainly	RB	RB	_	10	advmod	_	_
after	IN	B-PP	O	Other	###	12	after	after	IN	IN	_	14	case	_	_
chronic	JJ	B-NP	O	Other	###	13	chronic	chronic	JJ	JJ	_	14	amod	_	_
exposure	NN	I-NP	O	Other	###	14	exposure	exposure	NN	NN	_	10	nmod	_	_
to	TO	B-PP	O	Other	###	15	to	to	TO	TO	_	17	case	_	_
high	JJ	B-NP	O	Other	###	16	high	high	JJ	JJ	_	17	amod	_	_
concentrations	NNS	I-NP	O	Other	###	17	concentrations	concentrations	NNS	NNS	_	14	nmod	_	_
of	IN	B-PP	O	Other	###	18	of	of	IN	IN	_	19	case	_	_
IL-6	NN	B-NP	B-protein	B-Protein	###	19	IL-6	IL-6	NN	NN	_	17	nmod	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	7	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	3	det	_	_
limited	JJ	I-NP	O	Other	###	2	limited	limited	JJ	JJ	_	3	amod	_	_
efficacy	NN	I-NP	O	Other	###	3	efficacy	efficacy	NN	NN	_	15	nsubjpass	_	_
of	IN	B-PP	O	Other	###	4	of	of	IN	IN	_	6	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	5	IL-10	IL-10	NN	NN	_	6	compound	_	_
treatment	NN	I-NP	O	Other	###	6	treatment	treatment	NN	NN	_	3	nmod	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	9	case	_	_
RA	NN	B-NP	O	Other	###	8	RA	RA	NN	NN	_	9	compound	_	_
patients	NNS	I-NP	O	Other	###	9	patients	patients	NNS	NNS	_	6	nmod	_	_
[	(	O	O	Other	###	10	[	[	(	(	_	9	acl	_	_
50	CD	B-NP	O	Other	###	11	50	50	CD	CD	_	12	nummod	_	_
]	)	O	O	Other	###	12	]	]	)	)	_	10	dobj	_	_
may	MD	B-VP	O	Other	###	13	may	may	MD	MD	_	15	aux	_	_
be	VB	I-VP	O	Other	###	14	be	be	VB	VB	_	15	auxpass	_	_
explained	VBN	I-VP	O	Other	###	15	explained	explained	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	17	case	_	_
part	NN	B-NP	O	Other	###	17	part	part	NN	NN	_	15	nmod	_	_
by	IN	B-PP	O	Other	###	18	by	by	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	###	19	the	the	DT	DT	_	20	det	_	_
unresponsiveness	NN	I-NP	O	Other	###	20	unresponsiveness	unresponsiveness	NN	NN	_	15	nmod	_	_
to	TO	B-PP	O	Other	###	21	to	to	TO	TO	_	22	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	###	22	IL-10	IL-10	NN	NN	_	20	nmod	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	25	case	_	_
inflammatory	JJ	B-NP	B-cell_type	Other	###	24	inflammatory	inflammatory	JJ	JJ	_	25	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	###	25	cells	cells	NNS	NNS	_	22	nmod	_	_
,	,	O	O	Other	###	26	,	,	,	,	_	25	punct	_	_
including	VBG	B-PP	O	Other	###	27	including	including	VBG	VBG	_	29	case	_	_
T	NN	B-NP	B-cell_type	Other	###	28	T	T	NN	NN	_	29	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	29	cells	cells	NNS	NNS	_	25	nmod	_	_
.	.	O	O	Other	###	30	.	.	.	.	_	15	punct	_	_

On	IN	B-PP	O	Other	###	1	On	On	IN	IN	_	3	case	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	3	det	_	_
contrary	NN	I-NP	O	Other	###	3	contrary	contrary	NN	NN	_	16	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	16	punct	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	7	det	_	_
therapeutic	JJ	I-NP	O	Other	###	6	therapeutic	therapeutic	JJ	JJ	_	7	amod	_	_
efficacy	NN	I-NP	O	Other	###	7	efficacy	efficacy	NN	NN	_	16	nsubjpass	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	13	case	_	_
anti	NN	B-NP	O	Other	###	9	anti	anti	NN	NN	_	13	compound	_	_
-	-	O	O	Other	###	10	-	-	-	-	_	13	punct	_	_
IL-6	NN	B-NP	B-protein	B-Protein	###	11	IL-6	IL-6	NN	NN	_	13	compound	_	_
receptor	NN	B-NP	B-protein	I-Protein	###	12	receptor	receptor	NN	NN	_	13	compound	_	_
antibody	NN	I-NP	I-protein	Other	###	13	antibody	antibody	NN	NN	_	7	nmod	_	_
has	VBZ	B-VP	O	Other	###	14	has	has	VBZ	VBZ	_	16	aux	_	_
been	VBN	I-VP	O	Other	###	15	been	been	VBN	VBN	_	16	auxpass	_	_
reported	VBN	I-VP	O	Other	###	16	reported	reported	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	17	in	in	IN	IN	_	19	case	_	_
RA	NN	B-NP	O	Other	###	18	RA	RA	NN	NN	_	19	compound	_	_
patients	NNS	I-NP	O	Other	###	19	patients	patients	NNS	NNS	_	16	nmod	_	_
[	(	O	O	Other	###	20	[	[	(	(	_	16	xcomp	_	_
51	CD	B-NP	O	Other	###	21	51	51	CD	CD	_	22	nummod	_	_
]	)	O	O	Other	###	22	]	]	)	)	_	20	xcomp	_	_
,	,	O	O	Other	###	23	,	,	,	,	_	16	punct	_	_
and	CC	O	O	Other	###	24	and	and	CC	CC	_	16	cc	_	_
one	CD	B-NP	O	Other	###	25	one	one	CD	CD	_	33	nsubj	_	_
of	IN	B-PP	O	Other	###	26	of	of	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	27	the	the	DT	DT	_	28	det	_	_
effects	NNS	I-NP	O	Other	###	28	effects	effects	NNS	NNS	_	25	nmod	_	_
of	IN	B-PP	O	Other	###	29	of	of	IN	IN	_	31	case	_	_
this	DT	B-NP	O	Other	###	30	this	this	DT	DT	_	31	det	_	_
therapy	NN	I-NP	O	Other	###	31	therapy	therapy	NN	NN	_	28	nmod	_	_
may	MD	B-VP	O	Other	###	32	may	may	MD	MD	_	33	aux	_	_
be	VB	I-VP	O	Other	###	33	be	be	VB	VB	_	16	conj	_	_
to	TO	B-VP	O	Other	###	34	to	to	TO	TO	_	35	mark	_	_
normalize	VB	I-VP	O	Other	###	35	normalize	normalize	VB	VB	_	33	xcomp	_	_
T	NN	B-NP	B-cell_type	Other	###	36	T	T	NN	NN	_	37	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	37	cells	cells	NNS	NNS	_	35	dobj	_	_
through	IN	B-PP	O	Other	###	38	through	through	IN	IN	_	40	case	_	_
the	DT	B-NP	O	Other	###	39	the	the	DT	DT	_	40	det	_	_
inhibition	NN	I-NP	O	Other	###	40	inhibition	inhibition	NN	NN	_	35	nmod	_	_
of	IN	B-PP	O	Other	###	41	of	of	IN	IN	_	46	case	_	_
IL-6	NN	B-NP	B-protein	B-Protein	###	42	IL-6	IL-6	NN	NN	_	46	compound	_	_
-	-	O	O	Other	###	43	-	-	-	-	_	46	punct	_	_
dependent	NN	B-NP	O	Other	###	44	dependent	dependent	NN	NN	_	42	dep	_	_
STAT3	NN	I-NP	B-protein	B-Protein	###	45	STAT3	STAT3	NN	NN	_	46	compound	_	_
activation	NN	I-NP	O	Other	###	46	activation	activation	NN	NN	_	40	nmod	_	_
.	.	O	O	Other	###	47	.	.	.	.	_	16	punct	_	_

More	RBR	B-NP	O	Other	###	1	More	More	RBR	RBR	_	2	advmod	_	_
specific	JJ	I-NP	O	Other	###	2	specific	specific	JJ	JJ	_	3	amod	_	_
therapy	NN	I-NP	O	Other	###	3	therapy	therapy	NN	NN	_	9	nsubjpass	_	_
targeting	VBG	B-VP	O	Other	###	4	targeting	targeting	VBG	VBG	_	3	acl	_	_
STAT3	NN	B-NP	B-protein	B-Protein	###	5	STAT3	STAT3	NN	NN	_	6	compound	_	_
activation	NN	I-NP	O	Other	###	6	activation	activation	NN	NN	_	4	dobj	_	_
will	MD	B-VP	O	Other	###	7	will	will	MD	MD	_	9	aux	_	_
be	VB	I-VP	O	Other	###	8	be	be	VB	VB	_	9	auxpass	_	_
awaited	VBN	I-VP	O	Other	###	9	awaited	awaited	VBN	VBN	_	0	root	_	_
;	:	O	O	Other	###	10	;	;	:	:	_	9	punct	_	_
for	IN	B-PP	O	Other	###	11	for	for	IN	IN	_	12	case	_	_
example	NN	B-NP	O	Other	###	12	example	example	NN	NN	_	31	nmod	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	31	punct	_	_
the	DT	B-NP	O	Other	###	14	the	the	DT	DT	_	15	det	_	_
induction	NN	I-NP	O	Other	###	15	induction	induction	NN	NN	_	9	nsubjpass	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	19	case	_	_
the	DT	B-NP	O	Other	###	17	the	the	DT	DT	_	19	det	_	_
SOCS3	NN	I-NP	B-DNA	B-Protein	###	18	SOCS3	SOCS3	NN	NN	_	19	compound	_	_
gene	NN	I-NP	I-DNA	Other	###	19	gene	gene	NN	NN	_	15	nmod	_	_
,	,	O	O	Other	###	20	,	,	,	,	_	15	punct	_	_
the	DT	B-NP	O	Other	###	21	the	the	DT	DT	_	22	det	_	_
efficacy	NN	I-NP	O	Other	###	22	efficacy	efficacy	NN	NN	_	27	nsubjpass	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	24	case	_	_
which	WDT	B-NP	O	Other	###	24	which	which	WDT	WDT	_	22	nmod	_	_
has	VBZ	B-VP	O	Other	###	25	has	has	VBZ	VBZ	_	27	aux	_	_
been	VBN	I-VP	O	Other	###	26	been	been	VBN	VBN	_	27	auxpass	_	_
demonstrated	VBN	I-VP	O	Other	###	27	demonstrated	demonstrated	VBN	VBN	_	19	acl:relcl	_	_
in	IN	B-PP	O	Other	###	28	in	in	IN	IN	_	30	case	_	_
animal	JJ	B-NP	O	Other	###	29	animal	animal	JJ	JJ	_	30	amod	_	_
models	NNS	I-NP	O	Other	###	30	models	models	NNS	NNS	_	27	nmod	_	_
[	(	O	O	Other	###	31	[	[	(	(	_	9	parataxis	_	_
37	CD	B-NP	O	Other	###	32	37	37	CD	CD	_	33	nummod	_	_
]	)	O	O	Other	###	33	]	]	)	)	_	31	xcomp	_	_
.	.	O	O	Other	###	34	.	.	.	.	_	9	punct	_	_

